Research map: Factors associated with interferon-gamma release assay positivity in patients with psoriasis: a cross-sectional study

Back to the article

Papers in this map

  1. Risk prediction models: II. External validation, model updating, and impact assessment · Karel G.M. Moons · 2012 · 1206 citations · Cited by this paper
  2. High-risk human papillomavirus and risk of colorectal cancer: a preliminary study in South of Iran · 2026 · Related
  3. Evaluation of clinical prediction models (part 1): from development to external validation · Professor Gary S. Collins · 2024 · 719 citations · Cited by this paper
  4. Demographic and geographic disparities in mortality among U.S. adults with osteomyelitis: a CDC WONDER analysis, 1999–2023 · 2026 · Related
  5. British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update · Catherine Smith · 2020 · 260 citations · Cited by this paper
  6. Serum calpain-5 as a biomarker for disease severity and clinical outcomes in COVID-19 patients · 2026 · Related
  7. Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study · Ibrahim Abubakar · 2018 · 190 citations · Cited by this paper
  8. Epidemiology, vaccine effectiveness, and risk factors of pertussis in Xinjiang children: a retrospective study · 2026 · Related
  9. Psoriasis · April Wang Armstrong · 2025 · 187 citations · Cited by this paper
  10. Etiological characterization of acute respiratory tract infections and associated co-infections using Biofire respiratory 2.1 Plus panel · 2026 · Related
  11. The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection · Delia Goletti · 2022 · 171 citations · Cited by this paper
  12. Epidemiological trends of Crimean-Congo hemorrhagic fever in South Asia: a systematic review · 2026 · Related
  13. Screening for Latent Tuberculosis Infection in Adults · US Preventive Services Task Force · 2023 · 96 citations · Cited by this paper
  14. Universal SARS-CoV-2 RT-qPCR admission screening over 21 months in a German tertiary care hospital: detection of asymptomatic infections · 2026 · Related
  15. Screening for Latent Tuberculosis Infection in Adults · Daniel E Jonas · 2023 · 70 citations · Cited by this paper
  16. Long-term impact of COVID-19 on haemophilia: a multicenter study in Southwest China · 2026 · Related
  17. Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study · Tiago Torres · 2024 · 66 citations · Cited by this paper
  18. Evaluation of oxidative stress level: total antioxidant capacity, malondialdehyde and superoxide dismutase activity in children with pneumonia compared to healthy children · 2026 · Related
  19. Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort study · Christine S. Ho · 2021 · 37 citations · Cited by this paper
  20. Treatment of psoriasis with biologic and non‐biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN ‐ FRT expert consensus · Tiago Torres · 2024 · 23 citations · Cited by this paper
  21. Global Burden of Psoriasis from 1990 to 2021 and Potential Factors: A Systematic Analysis · Jiehua Wei · 2025 · 22 citations · Cited by this paper
  22. Advancing insights into psoriasis: from pathogenesis to current and emerging therapies · Maria Beatriz S. Gonçalves · 2025 · 17 citations · Cited by this paper
  23. Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors · Andrew Blauvelt · 2025 · 15 citations · Cited by this paper
  24. The association between diabetes status and latent-TB IGRA levels from a cross-sectional study in eastern China · Cheng Chen · 2023 · 13 citations · Cited by this paper
  25. Interleukin-17A Inhibitors in Patients with Psoriasis and Tuberculosis Infection: A 2-Year Prospective Study on Safety Without Preventive Treatment · Chun‐Xia He · 2024 · 13 citations · Cited by this paper
  26. A Propensity Score-Matched Study on the Changes of TB Status and TB-IGRA Values in Patients with Psoriasis with Latent TB Receiving Secukinumab · Yue Xiao · 2023 · 10 citations · Cited by this paper
  27. 2023 guidelines on the management of psoriasis by the Dermatological Society of Singapore · Hazel Hwee Boon Oon · 2024 · 10 citations · Cited by this paper
  28. Host factors associated with false negative results in an interferon‐γ release assay in adults with active tuberculosis · Quanxian Liu · 2023 · 9 citations · Cited by this paper
  29. Diagnosis and Treatment of Latent Tuberculosis Infection in Adults in South Korea · Kyung‐Wook Jo · 2024 · 7 citations · Cited by this paper
  30. Prevalence of Pretreatment Testing Recommended for Patients With Chronic Inflammatory Skin Diseases · Maria C. Schneeweiss · 2024 · 6 citations · Cited by this paper
  31. The role of chest X-rays when screening for latent tuberculosis infection in patients with inflammatory bowel disease before starting biologic treatment · Sebastian Bonde Christiansen · 2024 · 5 citations · Cited by this paper
  32. Prevalence of latent tuberculosis infection in older adults: a systematic review and meta-analysis · Yuxiao Ling · 2025 · 5 citations · Cited by this paper
  33. Management of Erythrodermic Psoriasis with Systemic Therapies: A Systematic Review · Luca Mastorino · 2025 · 4 citations · Cited by this paper
  34. Use of interferon-gamma release assay (IGRA) and CXCL-10/IP-10 for latent tuberculosis infection (LTBI) screening in chronic kidney disease and hemodialysis patients · Juliana Cristina Borges da Silva · 2025 · 4 citations · Cited by this paper
  35. Breaking the cycle of psoriasis: the role for early intervention · Thomas Graier · 2025 · 3 citations · Cited by this paper
  36. A practical guide to biologic treatments for psoriasis in resource-limited areas · Leena Chularojanamontri · 2025 · 3 citations · Cited by this paper
  37. Annual tuberculosis screening in patients on biologics has questionable value · Madison N. Kist · 2024 · 2 citations · Cited by this paper
  38. Association of clinical laboratory parameters with latent tuberculosis infection among healthcare workers of primary health centers―A cross-sectional observational study · Sivaprakasam T. Selvavinayagam · 2025 · 2 citations · Cited by this paper
  39. Update on Erythrodermic Psoriasis: Proposal of a Management Algorithm by an Innovative Severity Evaluation Approach · Jiaming Xu · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)